Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation

Area of Science:

• Bone Biology
• Skeletal Physiology
• Cellular and Molecular Biology

Background:

• Cathepsin K (CTSK) is crucial for bone resorption by osteoclasts.
• Global Ctsk deletion in mice leads to osteopetrosis and increased bone formation rate (BFR).
• The mechanism by which Ctsk deletion influences bone formation remains unclear.

Purpose of the Study:

• To investigate the role of osteoclast-specific Cathepsin K in regulating bone formation.
• To elucidate the molecular pathways linking Ctsk deletion to enhanced bone formation.
• To determine if the increased BFR is dependent on osteoclast activity.

Main Methods:

• Generation of osteoclast- and osteoblast-targeted Ctsk knockout mice using floxed Ctsk alleles.
• Analysis of bone volume, BFR, osteoclast, and osteoblast numbers in knockout models.
• Assessment of sphingosine kinase 1 (Sphk1) expression and sphingosine-1-phosphate (S1P) levels in osteoclasts.
• In vitro studies using osteoblast cultures treated with conditioned media from Ctsk-deficient osteoclasts.
• Evaluation of the RANKL/OPG ratio in osteoblasts.

Main Results:

• Targeted deletion of Ctsk in osteoclasts, but not osteoblasts, significantly increased bone volume, BFR, and cell numbers.
• Ctsk deficiency in osteoclasts led to increased Sphk1 expression and elevated S1P levels.
• Osteoblast cultures treated with S1P-rich media showed increased alkaline phosphatase and mineralization.
• An S1P receptor antagonist blocked these osteoblast responses.
• Osteoblasts from Ctsk-deficient osteoclast models exhibited an elevated RANKL/OPG ratio.

Conclusions:

• Osteoclast-derived Cathepsin K negatively regulates bone formation.
• Deletion of CTSK in osteoclasts enhances bone formation in vivo via increased osteoclast-derived S1P.
• This mechanism involves S1P signaling to osteoblasts and a positive feedback loop on osteoclastogenesis.
• Targeting CTSK in osteoclasts represents a potential therapeutic strategy for bone loss conditions.